Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXH3SX
|
||||
Drug Name |
4-(5-{[2-(3,5-Difluoro-benzyl)-3-oxo-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-ylamino]-methyl}-imidazol-1-ylmethyl)-benzonitrile
|
||||
Synonyms |
CHEMBL350736
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H25F2N5O
|
||||
Canonical SMILES |
Fc1cc(F)cc(CN2Cc3ccccc3CC(NCc4cncn4Cc5ccc(cc5)C#N)C2=O)c1
|
||||
InChI |
InChI=1S/C29H25F2N5O/c30-25-9-22(10-26(31)12-25)17-35-18-24-4-2-1-3-23(24)11-28(29(35)37)34-15-27-14-33-19-36(27)16-21-7-5-20(13-32)6-8-21/h1-10,12,14,19,28,34H,11,15-18H2
|
||||
InChIKey |
TWNBGUAWTJEEOF-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.